The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Obesity paradox after percutaneous coronary intervention - closing in on the truth behind the phenomenon

EuroIntervention 2020;15:1120-1122. DOI: 10.4244/EIJV15I13A208

1. Deutsches Herzzentrum München, Technische Universität, Munich, Germany; 2. DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany

Obesity is a well-recognised risk factor with a likely causal relationship with cardiovascular disease (CVD). Obesity has reached epidemic proportions and is trending upward globally1. Despite the negative impact of obesity on cardiovascular health, it has been repeatedly demonstrated that, when CVD occurs, there is a moderate-term survival advantage of being overweight or mildly obese compared with thinner patients with the same CVD2. This pattern of relationship is called the obesity paradox. The obesity paradox has been demonstrated across a wide range of CVD3 and cardiovascular therapy including percutaneous coronary intervention (PCI)4. Although knowledge about the obesity paradox after ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
No room at the inn? Pulmonary artery stent implantation and the fate of the bronchus